blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1976503

EP1976503 - GASTRIC RETENTIVE GABAPENTIN DOSAGE FORMS AND METHODS FOR USING SAME [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  15.03.2013
Database last updated on 02.11.2024
Most recent event   Tooltip15.03.2013Refusal of applicationpublished on 17.04.2013  [2013/16]
Applicant(s)For all designated states
Depomed, Inc.
1360 O'Brien Drive
Menlo Park, CA 94025 / US
[2008/41]
Inventor(s)01 / BERNER, Bret
424 Lee Avenue
Half Moon Bay, California 94019 / US
02 / HOU, Sui Yuen Eddie
380 Shad Court
Foster City, California 94404 / US
03 / GANA, Theophilus J.
200 Lawson Road SE
Leesburg, Virginia 20175 / US
04 / CRAMER, Marilou S.
1736 Kansas Street
Redwood City, California 94061 / US
 [2008/41]
Representative(s)Brasnett, Adrian Hugh, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2008/41]Brasnett, Adrian Hugh, et al
Mewburn Ellis LLP York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date06848292.629.12.2006
[2008/41]
WO2006US49511
Priority number, dateUS2005032244829.12.2005         Original published format: US 322448
US20060852534P17.10.2006         Original published format: US 852534 P
[2008/41]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007079195
Date:12.07.2007
Language:EN
[2007/28]
Type: A2 Application without search report 
No.:EP1976503
Date:08.10.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 12.07.2007 takes the place of the publication of the European patent application.
[2008/41]
Search report(s)International search report - published on:EP30.08.2007
ClassificationIPC:A61K31/195, A61K9/00, A61P25/00
[2008/41]
CPC:
A61K9/0065 (EP); A61K31/135 (EP); A61K31/195 (EP);
A61K31/197 (EP); A61K31/4166 (EP); A61K31/53 (EP);
A61K31/55 (EP); A61K45/06 (EP); A61P25/00 (EP);
A61P25/04 (EP); A61P25/06 (EP); A61P25/08 (EP);
A61P25/24 (EP); A61P29/00 (EP); A61P29/02 (EP);
A61P43/00 (EP); A61P5/12 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/41]
TitleGerman:MAGENRETENTIVE GABAPENTIN-DOSIERFORMEN UND ANWENDUNGSVERFAHREN[2008/41]
English:GASTRIC RETENTIVE GABAPENTIN DOSAGE FORMS AND METHODS FOR USING SAME[2008/41]
French:FORMES POSOLOGIQUES DE GABAPENTINE A RETENTION GASTRIQUE ET LEURS PROCEDES D'UTILISATION[2008/41]
Entry into regional phase17.07.2008National basic fee paid 
17.07.2008Designation fee(s) paid 
17.07.2008Examination fee paid 
Examination procedure08.07.2008Amendment by applicant (claims and/or description)
17.07.2008Examination requested  [2008/41]
06.11.2008Despatch of a communication from the examining division (Time limit: M06)
24.06.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
01.09.2009Reply to a communication from the examining division
09.02.2012Cancellation of oral proceeding that was planned for 07.03.2012
07.03.2012Date of oral proceedings (cancelled)
05.11.2012Cancellation of oral proceeding that was planned for 08.11.2012
08.11.2012Date of oral proceedings (cancelled)
29.11.2012Despatch of communication that the application is refused, reason: substantive examination [2013/16]
09.12.2012Application refused, date of legal effect [2013/16]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.11.2008
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
01.09.2009Request for further processing filed
01.09.2009Full payment received (date of receipt of payment)
Fees paidRenewal fee
24.12.2008Renewal fee patent year 03
28.12.2009Renewal fee patent year 04
27.12.2010Renewal fee patent year 05
27.12.2011Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.12.201207   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DXY]US2003100611  (BERNER BRET [US], et al) [DXY] 1-71 * examples 1-4; claims 20-29,36,78-87,94 * * paragraphs [0006] , [0012] , [0025] , [0026] , [0032] , [0040] - [0042] *;
 [XY]US2005064036  (BERNER BRET [US], et al) [XY] 1-71 * claims 1,2,21,24 * * paragraphs [0005] , [0013] , [0026] , [0033] , [0038] , [0041] , [0043] * * examples 1-8 *;
 [XY]US2003104053  (GUSLER GLORIA [US], et al) [XY] 1-71 * claims 1,16,20 * * paragraphs [0004] , [0017] * * example 2 *;
 [Y]US2003031711  (FARA JOHN W [US], et al) [Y] 1-71 * claims 1-4,20 *;
 [DY]US6310098  (GUTTUSO JR THOMAS J [US]) [DY] 1-71 * claims 1,3,7 *;
 [PX]US2006159743  (BERNER BRET [US], et al) [PX] 1-71 * claims 1-44 *
 [Y]  - BENNETT M I ET AL, "GABAPENTIN IN THE TREATMENT OF NEUROPATHIC PAIN", PALLIATIVE MEDICINE, LONDON, GB, (200401), vol. 18, no. 1, ISSN 0269-2163, pages 5 - 11, XP009047587 [Y] 1-71 * page 7, column 2, paragraph 3 - page 8, column 2, paragraph 3 *

DOI:   http://dx.doi.org/10.1191/0269216304pm845ra
 [Y]  - RICHTER R W ET AL, "PREGABALIN OR MORPHINE AND GABAPENTIN FOR NEUROPATHIC PAIN", EXPERT OPINION ON PHARMACOTHERAPY, ASHLEY, LONDON,, GB, (200511), vol. 6, no. 14, ISSN 1465-6566, pages 2535 - 2539, XP009075939 [Y] 1-71 * whole document *

DOI:   http://dx.doi.org/10.1517/14656566.6.14.2535
 [Y]  - WESCHE D ET AL, "A pharmacokinetic comparison of pregabalin and gabapentin", JOURNAL OF PAIN, SAUNDERS, PHILADELPHIA, PA, US, (200503), vol. 6, no. 3, ISSN 1526-5900, page S29, XP004796228 [Y] 1-71 * abstract *

DOI:   http://dx.doi.org/10.1016/j.jpain.2005.01.114
Examination   - PANDYA K J ET AL, "Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial", THE LANCET, LANCET LIMITED. LONDON, GB, vol. 366, no. 9488, doi:10.1016/S0140-6736(05)67215-7, ISSN 0140-6736, (20050903), pages 818 - 824, (20050903), XP025277585

DOI:   http://dx.doi.org/10.1016/S0140-6736(05)67215-7
    - GUTTUSO THOMAS JR ET AL, "Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial.", OBSTETRICS AND GYNECOLOGY FEB 2003 LNKD- PUBMED:12576259, (200302), vol. 101, no. 2, ISSN 0029-7844, pages 337 - 345, XP009156371

DOI:   http://dx.doi.org/10.1016/S0029-7844(02)02712-6
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.